ProfileGDS5678 / 1449075_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 36% 34% 38% 38% 37% 34% 36% 37% 37% 38% 37% 38% 37% 42% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.8658536
GSM967853U87-EV human glioblastoma xenograft - Control 22.7814334
GSM967854U87-EV human glioblastoma xenograft - Control 32.8668738
GSM967855U87-EV human glioblastoma xenograft - Control 42.8235938
GSM967856U87-EV human glioblastoma xenograft - Control 52.8021237
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.8555834
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.8850536
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.8398337
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.822637
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.8510438
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.8287637
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.8274838
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.8541537
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.9696342